|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 630 | - | - | 476 | 75.6 | 75 | 11.9 | 53 | 8.4 | 26 | 4.1 |
| 2015-2019 | 577 | - | - | 437 | 75.7 | 62 | 10.7 | 51 | 8.8 | 27 | 4.7 |
| 2014-2018 | 517 | - | - | 398 | 77.0 | 53 | 10.3 | 39 | 7.5 | 27 | 5.2 |
| 2013-2017 | 508 | - | - | 392 | 77.2 | 54 | 10.6 | 35 | 6.9 | 27 | 5.3 |
| 2012-2016 | 526 | - | - | 412 | 78.3 | 55 | 10.5 | 35 | 6.7 | 24 | 4.6 |
| 2011-2015 | 549 | - | - | 448 | 81.6 | 54 | 9.8 | 28 | 5.1 | 19 | 3.5 |
| 2010-2014 | 562 | - | - | 464 | 82.6 | 58 | 10.3 | 26 | 4.6 | 14 | 2.5 |
| 2009-2013 | 602 | - | - | 505 | 83.9 | 56 | 9.3 | 29 | 4.8 | 12 | 2.0 |
| 2008-2012 | 631 | - | - | 535 | 84.8 | 53 | 8.4 | 30 | 4.8 | 13 | 2.1 |
| 2007-2011 | 700 | - | - | 600 | 85.7 | 56 | 8.0 | 29 | 4.1 | 15 | 2.1 |
| 2006-2010 | 707 | - | - | 595 | 84.2 | 62 | 8.8 | 29 | 4.1 | 21 | 3.0 |
| 2005-2009 | 690 | - | - | 578 | 83.8 | 58 | 8.4 | 29 | 4.2 | 25 | 3.6 |
| 2004-2008 | 673 | - | - | 555 | 82.5 | 60 | 8.9 | 29 | 4.3 | 29 | 4.3 |
| 2003-2007 | 658 | - | - | 532 | 80.9 | 59 | 9.0 | 27 | 4.1 | 40 | 6.1 |
| 2002-2006 | 575 | 1 | 0.2 | 457 | 79.5 | 48 | 8.3 | 26 | 4.5 | 43 | 7.5 |
| 2001-2005 | 563 | 1 | 0.2 | 457 | 81.2 | 34 | 6.0 | 26 | 4.6 | 45 | 8.0 |
| 2000-2004 | 561 | 1 | 0.2 | 459 | 81.8 | 34 | 6.1 | 19 | 3.4 | 48 | 8.6 |
| 1999-2003 | 547 | 1 | 0.2 | 440 | 80.4 | 26 | 4.8 | 14 | 2.6 | 66 | 12.1 |
| 1998-2002 | 504 | 1 | 0.2 | 409 | 81.2 | 22 | 4.4 | 9 | 1.8 | 63 | 12.5 |
| 1997-2001 | 523 | 1 | 0.2 | 384 | 73.4 | 24 | 4.6 | 8 | 1.5 | 106 | 20.3 |
| 1996-2000 | 481 | 1 | 0.2 | 318 | 66.1 | 23 | 4.8 | 8 | 1.7 | 131 | 27.2 |
| 1995-1999 | 448 | 2 | 0.4 | 268 | 59.8 | 22 | 4.9 | 10 | 2.2 | 146 | 32.6 |
| 1994-1998 | 423 | 2 | 0.5 | 241 | 57.0 | 30 | 7.1 | 13 | 3.1 | 137 | 32.4 |
| 1993-1997 | 423 | 2 | 0.5 | 227 | 53.7 | 38 | 9.0 | 20 | 4.7 | 136 | 32.2 |
| 1992-1996 | 466 | 1 | 0.2 | 271 | 58.2 | 53 | 11.4 | 28 | 6.0 | 113 | 24.2 |
| 1991-1995 | 542 | 1 | 0.2 | 326 | 60.1 | 69 | 12.7 | 29 | 5.4 | 117 | 21.6 |
| 1990-1994 | 592 | 1 | 0.2 | 374 | 63.2 | 69 | 11.7 | 31 | 5.2 | 117 | 19.8 |
| 1989-1993 | 589 | 2 | 0.3 | 375 | 63.7 | 66 | 11.2 | 31 | 5.3 | 115 | 19.5 |
| 1988-1992 | 594 | 2 | 0.3 | 380 | 64.0 | 68 | 11.4 | 31 | 5.2 | 113 | 19.0 |
| 1987-1991 | 514 | 3 | 0.6 | 332 | 64.6 | 57 | 11.1 | 26 | 5.1 | 96 | 18.7 |
| 1986-1990 | 411 | 4 | 1.0 | 275 | 66.9 | 41 | 10.0 | 25 | 6.1 | 66 | 16.1 |
| 1985-1989 | 334 | 3 | 0.9 | 216 | 64.7 | 40 | 12.0 | 28 | 8.4 | 47 | 14.1 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |